SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-130592
Filing Date
2024-11-25
Accepted
2024-11-25 16:30:03
Documents
1
Period of Report
2024-11-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 2904
  Complete submission text file 0000950170-24-130592.txt   4441
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1300 N. KELLOGG DRIVE, SUITE D ANAHEIM CA 92807
Business Address
Mulroy Michael H. (Reporting) CIK: 0001509725 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12830 | Film No.: 241496315